ArticleFrontiers in medicine2026
A perspective on precision medicine in obstructive sleep apnea: from pathophysiological phenotyping to integrated management pathways.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive sleep apnea (OSA) is a condition defined by complex biological causes and highly varied symptoms. The traditional "one-size-fits-all" treatment approach, which depends on a single measurement like the Apnea-Hypopnea Index (AHI), frequently fails to provide individualized care, leading to poor results and low treatment adherence for many patients. Precision medicine offers a solution by using many different types of data to create detailed patient profiles. This data includes the specific physical causes of a patient's OSA, their unique symptoms and other health conditions, biological markers, and information from ongoing monitoring. This detailed profiling allows doctors to group patients more precisely and match them to targeted treatments, such as procedures to open the airway, medications to stabilize breathing, and personalized lifestyle changes. The goal is to shift OSA care from a focus on standardized devices to plans built around the individual patient. To make this future a reality, the medical field needs standardized tools for patient profiling, strong clinical trials to prove these new methods work, and better teamwork across medical specialties. This coordinated effort is essential to make care for OSA more effective, personalized, and accessible to all who need it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.